Benefit of Neoral C2 monitoring in de novo cardiac transplant recipients receiving basiliximab induction.
Cantarovich M, Ross H, Arizón JM, Gómez MA, Straatman L, Orús J, Alonso-Pulpón L, Molina BD, Wang S, Lage E, Crespo MG, Manito N, Howlett J, Haddad H; Motown Study Group.
Cantarovich M, et al. Among authors: ross h.
Transplantation. 2008 Apr 15;85(7):992-9. doi: 10.1097/TP.0b013e318169bf43.
Transplantation. 2008.
PMID: 18408580
Clinical Trial.